openPR Logo
Press release

Innovation to trigger the Antibodies Contract Manufacturing Market

The Antibodies Contract Manufacturing Market shall be growing unabatedly in the future. The healthcare vertical is expected to go “personalized” in the next 10 years. Thus, genomics and genetics, along with the other biologic information, going personalized will help in early diagnosis of the disease and also how patients will respond to the treatments. Likewise, the healthcare vertical would be there to make greater strides in the forecast period.

As per Persistence Market Research’s latest industry analysis, the global antibodies contract manufacturing market was valued at US$ 3.87 Bn in 2020, and is expected to exhibit a high CAGR of close to 13% over the forecast period (2021-2031).

Rising prevalence cancer and infectious diseases is creating rapid development and commercialization need for biopharmaceutical therapeutics. Ultimately, rise in the prevalence of both conditions is expected to drive the need for biologics.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/32933

With advancements in contract solutions, leading CDMOs are focusing on the expansion of their integrated capabilities from molecule-to-finished product. The trend is significant as the acceleration of development and speed to market is becoming more crucial for biopharmaceutical and biologics developers.

Owing to their high specificity and favorable safety profile associated with antibodies, contract manufacturing outsourcing presently comprises the largest class of biologics in the business, owing to legacy challenges related to the development and manufacturing of biologics.

For example, in July 2020, Avid Bioservices and Argonaut Manufacturing Services entered into agreement to offer biotechnology and pharmaceutical clients integrated process development, drug substance manufacturing, and drug product parenteral manufacturing, to accelerate the development and commercialization of biopharmaceutical therapeutics.

Focusing on reduction in operating costs through outsourcing of R&D and commercialization of antibodies to CMOs/CDMOs could increase operational efficiency. Outsourcing at later stages of clinical development through identification and appointment of a strategic partner could improve efficiencies all along the value chain.

The current biologics-development pipeline supports an outlook of continued healthy growth. The number of biotech patents applied for every year has been growing at approximately 23% annually. According to Persistence Market Research, there are currently more than 1,500 biomolecules undergoing clinical trials, which targeting more than 100 hundred types of diseases, and the success rate for biologics has so far been over twice that of small-molecule products.

Key Takeaways from Market Study

In terms of product, monoclonal antibodies hold around 89% market value share.

Based on expression system, the mammalian segment is leading with over 84.1% market.

Based on company size, mid-sized companies account the largest market share of 45.9%.

By scale of operation, commercial operations account for 54.3% market share.

By region, North America is set dominate the global antibodies contract manufacturing market with a value share of around 37.9% in 2021. Europe is slated to be the second-largest market with a value share of around 29.7% in 2021.

“Strong biologics pipeline and growing contract manufacturing service adoption are expected to drive market growth over the coming years,” says an analyst of Persistence Market Research.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32933

Company Profiles:

AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific.
AbbVie, Inc.

Market Competition

New product launches and approvals, agreements, expansion, acquisition collaborations, and partnerships have emerged as key growth strategies being adopted by industry players. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.

In February 2021, Avid Bioservices, Inc. began phase 2 expansion of its Myford manufacturing capacity expansion plan. This expansion will help the company cater the growing demand for contract manufacturing services.

Rentschler Biopharma, in May 2020, entered into a collaboration with Genemab for the development and manufacturing of bispecific antibodies generated with Genmab’s DuoBody Technological Platform.

In August 2018, KBI Biopharma’s subsidiary KBI Biopharma BVBA established its new laboratory in Belgium. With this expansion, the company will be able to offer analytical services in the European market.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the antibodies contract manufacturing market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on product (monoclonal antibodies, antibody fragments, and polyclonal antibodies), expression system (mammalian and microbial {bacteria and yeast}), company size (small, mid-sized, large, and very large), and scale of operation (preclinical, clinical, and commercial), across seven key regions of the world.

For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/32933

Access Related reports-

Endoscopic Spinal Surgery Market: https://www.persistencemarketresearch.com/market-research/endoscopic-spinal-surgery-market.asp

Immune Repertoire Sequencing Market: https://www.persistencemarketresearch.com/market-research/immune-repertoire-sequencing-market.asp

Non-invasive Prenatal Testing (NIPT) Market: https://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market.asp

Automated Cell Counters Market: https://www.persistencemarketresearch.com/market-research/automated-cell-counters-market.asp

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Innovation to trigger the Antibodies Contract Manufacturing Market here

News-ID: 2490792 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Biopharma

Global Biopharma Outsourcing Market 2022 Future Set to Massive Growth | Major Pl …
The "Global Biopharma Outsourcing Market Analysis to 2030" is a particular and top to bottom analysis of the Biopharma Outsourcing industry with an emphasis on the worldwide market trend. The report expects to provide an overview of worldwide Biopharma Outsourcing market detailed market segmentation by service, organization mode, application and geography. The worldwide Biopharma Outsourcing market is predictable to witness high growth during the forecast period. The report gives key
Biopharma Outsourcing Global Market Outlook - BioPharma Services, Lambda Therape …
The Biopharma Outsourcing Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Biopharma Outsourcing market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of
Biopharma Outsourcing Market 2019: Top Key Players are Sartorius, Emcure Pharmac …
Biopharma Outsourcing Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ - https://www.researchreportsworld.com/enquiry/request-sample/13899552 Global Biopharma Outsourcing market 2019 research provides a basic overview of the industry including definitions,
Biopharma Outsourcing Market by Top players - Sartorius, Emcure Pharmaceuticals, …
The new report on the global Biopharma Outsourcing market provides key insights into the Biopharma Outsourcing market. The market report is ideal for customers looking to gain actionable insights into the market which can assist them in furthering their business. The global report provides a detailed analysis of all the parameters within the Biopharma Outsourcing market. The market report pegs the global Biopharma Outsourcing market at US$ XX million at
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and
Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 | Key Players : Sartorius, Emcure Pharmaceuticals, BioPharma Services, Baxter Healthcare, Keyrus Biopharma, Quintiles”. Description:- Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base. Scope of the Report: This market encompasses various contract companies that provide clinical trials, drug